The Structural Disease Center

Filter Your Results

 

News

 

Edwards Acquires Harpoon Medical

December 6, 2017 -- Edwards Lifesciences announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company focused on beating-heart repair for de…

Five-Year Data on LAA Closure Using Watchman Device in Patients With Nonvalvular Atrial Fibrillation Presented, Published

November 2, 2017 -- Five-year results from the PREVAIL trial comparing left atrial appendage (LAA) closure with the Watchman device (Boston Scientific Corporation) to warfarin…

An Interview With Didier Tchétché, MD

September/October 2017—Dr. Tchétché discusses what is on the horizon for valvular disease intervention, new features at his clinic in France, and how he prepares for live case presentations.

United States Arm of ALIVE Study Begins for BioVentrix Revivent TC System

October 4, 2017 -- BioVentrix, Inc. announced enrollment of the first patient in the United States arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrat…

Enrollment Completed in Pivotal Trial of Essential Medical's Manta Large-Bore Vascular Closure Device

October 2, 2017 -- Essential Medical, Inc. announced the completion of enrollment in the United States pivotal trial of its Manta large-bore vascular closure device. The trial…

Enrollment Completed in Pivotal ASSURED Study of Gore's Cardioform ASD Occluder

September 26, 2017 -- Gore & Associates announced the completion of enrollment for the pivotal phase of the ASSURED clinical study, which is evaluating the interventional …

FDA Approves Abiomed's Impella RP System for Right Heart Failure

September 20, 2017 -- Abiomed, Inc. announced that it has received US Food and Drug Administration (FDA) premarket approval (PMA) for the Impella RP heart pump. The percutaneo…

Long-Term Outcomes of PFO Closure Versus Medical Therapy after Stroke Compared in RESPECT Trial

September 19, 2017 -- In The New England Journal of Medicine (NEJM), Jeffrey L. Saver, MD, et al published findings from the RESPECT trial that investigated long-term outcomes…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.